Relation of AURKB over-expression to low survival rate in BCRA and reversine-modulated aurora B kinase in breast cancer cell lines

• Published in: Cancer cell international 2019-06, Vol.19 (1), p.166-166, Article 166
• Main Authors: Huang, Di, Huang, Yu, Huang, Zisheng, Weng, Jiefeng, Zhang, Shuai, Gu, Weili
• Format: Article
• Language: English
• Subjects: Apoptosis; AURKB; Aurora B; Aurora B protein; Aurora kinase; BAX protein; Bcl-2 protein; BRCA; Breast cancer; Cancer therapies; Caspase; Caspase-3; Cell cycle; Cell lines; Cell proliferation; Cell viability; Chemical compounds; Enzyme inhibitors; ErbB-2 protein; Fibroblasts; Flow cytometry; Gelatinase B; Genes; Invasiveness; Kinases; Medical prognosis; Metastases; MicroRNAs; miRNA; Overexpression; Polymerase chain reaction; Polyploidy; Primary Research; Proteins; Reversine; Stem cells; Survival; Tissue inhibitor of metalloproteinase 1; Transforming growth factor-b1; Triple-negative breast cancer cells; Tumor cell lines; Viability
• ISSN: 1475-2867; 1475-2867
• DOI: 10.1186/s12935-019-0885-z

New therapeutic drug for breast cancer (BRCA), especially triple negative BRCA (TNBC), is urgently needed. Even though 2-(4-morpholinoanilino)-6-cyclohexylaminopurine (reversine) is an aurora kinase inhibitor, it also inhibits some cancer cells and human BRCA cells. However, the potential roles of reversine as a novel therapeutic agent for the treatment of BRCA remains unknown and must be further investigation. Thus, the relationship of reversine to aurora kinase in BCRA has not been reported. The relationship between AURKB and survival rate in BRCA has never been reported. Herein, we tested the roles of reversine on different BRCA cell line subtypes. We also investigated the relationship between AURKB and survival rate in BRCA as well as reversine to Aurora kinase expression in BCRA cell lines, including TNBC subtype, 4T1, MDA-MB-231, and luminal subtype MCF-7. Cell viability and apoptosis were detected using Cell Counting Kit-8 and flow cytometry analysis, respectively. Apoptotic and tumor-related proteins were tested using Western blot analysis. Important microRNAs that regulate BRCA were analyzed using RT-PCR. UALCAN public databases were used to analyze the targeted gene profiles, and the PROGgeneV2 database was used to study the prognostic implications of genes. Reversine inhibits cell proliferation and induces cell apoptosis by modulating caspase-3 and bax/bcl-2 among the three cell lines. Data from the UALCAN public database show that BRCA tissues expressed high gene levels of , and compared with the normal tissue. Among the over-expressed genes in BRCA, ranks 9th in TNBC, 49th in luminal subtype, and 48th in HER2 subtype. High level in BRCA is highly related to the low survival rate in patients displayed in 18 databases searched via PROGgeneV2. The protein levels of aurora B kinase (Aurora B), which is encoded by gene, are highly suppressed by reversine in the three cell lines. The tumor-related proteins TGF-β1, TIMP1, and MMP9 are partially suppressed by reversine but with different sensitivity in the three cell lines. The reversine-affected microRNAs, such as miR129-5p, miR-199a-3p, and miR-3960, in MDA-MB-231 cell line might be the research targets in TNBC regulation. In BRCA, the level of are over-expressed and is related to low survival rate. Reversine contributes to anti-growth effect in BRCA cell lines, especially for TNBC, by modulating the aurora B. However, the invasiveness, metastasis, and anti-tumor effects of reversine in vivo and in